Journals / Journal of the Turkish-German Gynecological Association / 2011 / Cilt: 12 - Sayı: 1

Plasenta previa perkreata’lı olgunun plasental dokunun çıkarılmadan, arter ligasyonu ve adjuvan metotreksat terapisi ile konservatif yönetimi

Conservative management of placenta previa percreta by leaving placental tissue in situ with arterial ligation and adjuvant methotrexate therapy

Pages
127–129
Publication Date
2022-10-18
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

We describe a case of placenta previa percreta which we managed successfully with conservative modalities. (J Turkish-German Gynecol Assoc 2011; 12: 127-9)

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Placenta percreta is one of the life-threatening conditions in modern obstetrics.
📊
Key Findings & Data:The rising caesarean section rate means rising placenta percreta rate.
💡
Conclusion & Impact:We describe a case of placenta previa percreta which we managed successfully with conservative modalities. (J Turkish-German Gynecol Assoc 2011; 12: 127-9)
🔬Design:Research Article
📍Scope:2011 Verileri
⚙️Variables:Domain Parameters

Abstract

Placenta percreta is one of the life-threatening conditions in modern obstetrics. The rising caesarean section rate means rising placenta percreta rate. Treatment strategies range from a caesarean hysterectomy to leaving the placenta in situ with or without internal iliac artery ligation/uterine artery embolisation and/or methotrexate therapy. We describe a case of placenta previa percreta which we managed successfully with conservative modalities. (J Turkish-German Gynecol Assoc 2011; 12: 127-9)

Özet

Plasenta perkreata modern obstetrideki hayatı tehdit eden patolojilerden biridir. Artan sezaryen doğum oranı artan plasenta perkreata oranı anlamına gelmektedir. Tedavi stratejileri sezaryen histerektomiden plasentanın içeride bırakılması veya internal iliak arter ligasyonu/ uterin arter embolizasyonu ve/veya metotreksat tedavisine kadar uzanmaktadır. Bu yazıda konservatif yöntemler kullanarak başarılı şekilde yönettiğimiz bir plasenta previa perkreata tanılı olguyu takdim etmekteyiz. (J Turkish-German Gynecol Assoc 2011; 12: 127-9)

🔖

Cite This Article

SANHAL, C. Y., ÇIRPAN, T., ÖZŞENER, S., YÜCEBİLGİN, S. (2022). Plasenta previa perkreata’lı olgunun plasental dokunun çıkarılmadan, arter ligasyonu ve adjuvan metotreksat terapisi ile konservatif yönetimi. Journal of the Turkish-German Gynecological Association, Cilt: 12 - Sayı: 1, 127–129. https://ajindex.com/articles/567720

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (1)

  1. Wu S, Kocherginsky M, Hibbard JU. Abnormal placentation: twenty year analysis. Am J Obstet Gynecol 2005; 192: 1458-61. [CrossRef] 2. Sherer DM, Gorelick C, Zigalo A, Sclafani S, Zinn HL, Abulafia O. Placenta previa percreta managed conservatively with methotrexate and multipl bilateral uterine artery embolizations. Ultrasound Obstet Gynecol 2007; 30: 227-8. [CrossRef] 3. Harris RD, Cho C, Wells WA. Sonography of the placenta with emphasis on pathological correlation. Semin Ultrasound CT MR 1996; 17: 66-89. [CrossRef] 4. Read JA, Cotton DB, Miller FC. Placenta accreta: changing clinical aspects and outcome. Obstet Gynecol 1980; 56: 31-4. 5. Chattopadhyay SK, Kharif H, Sherbeeni MM. Placenta praevia and accreta after previous caesarean section. Eur J Obstet Gynecol Reprod Biol 1993; 52: 151- 643. [CrossRef] 6. O’Brien JM, Barton JR, Donaldson ES. The management of placenta percreta: Conservative and operative strategies. Am J Obstet Gynecol 1996; 175: 1632-8. 7. Comstock CH, Love JJ Jr, Bronsteen RA, Lee W, Vettraino IM, Huang RR, et al. Sonographic detection ofplacenta accreta in the second and third trimesters of pregnancy. Am J Obstet Gynecol 2004; 190: 1135-40. [CrossRef] 8. Lax A, Prince M, Mennitt KW, Schwebach JR, Budorick NE. The value of specific MRI features in the evaluation of suspected placental invasion. Magnetic Resonance Imaging 2007; 25: 87-93. [CrossRef] 9. Committee on Obstetric Practice. ACOG committee opinion. Placenta accreta. Int J Gynaecol Obstet 2002; 77: 77-8 10. Arulkumaran S, Ng CS, Ingemarsson I, Ratnam SS. Medical treatment of placenta accreta with methotrexate. Acta Obstetrica Gynecologica Scandinavica 1986; 65: 285-6. [CrossRef] 11. O’Brien JM, Barton JR, Donaldson ES. The management of placenta percreta: conservative and operative strategies. American Journal of Obstetrics and Gynecology 1996; 175: 1632-8. 12. Lam H, Puna TC, Lamb PW. Successful conservative management of placenta previa accreta during cesarean section. Inter Journ of Gynecol and Obstetr 2004; 86: 31-2. [CrossRef] 13. Crespo R, Lapresta M, Madani B. Conservative treatment of placenta increta with methotrexate. International Journal of Gynecology and Obstetrics 2005; 91: 162-3. [CrossRef]